Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Keri A. Streby
Biography
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Keri A. Streby
Biography
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Keri A. Streby
Contact Information
- Call us at:
- (614) 722-3550
- Fax us at:
- (614) 722-3369
- PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Keri A. Streby
Biography
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Biography
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Biography
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Dr. Streby is a pediatric oncologist in the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital and an assistant professor at The Ohio State University. Dr. Streby received her undergraduate degree from the University of Akron and completed her medical degree from Northeastern Ohio Universities College of Medicine. She went on to complete her pediatric residency and pediatric hematology/oncology fellowship at Nationwide Children’s Hospital. Dr. Strebys research and clinical interests are focused on embryonal solid tumors, especially neuroblastoma. Her current research utilizes an oncolytic herpes virus and gene therapy to enhance targeted radiotherapy with 131I-mIBG for children with neuroblastoma.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
- Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
- Hematology/Oncology & BMT
- Physician Team
- Hematology, Oncology and BMT Fellowship
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Hematology & Oncology
Research
Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
Research
Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
Research
Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
View More Publications
- Desai AV, Elmuti L, Cahaney C, De Guzman RM, Streby KA, Cohn SL. Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 Jan 31; e30227.
- Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2022 Oct 7; JCO2201273.
- Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research. Children (Basel). 2022 Jun 16; 9:
Education
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
Education
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
Education
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
Date of Appointment at Nationwide Children’s Hospital: 07/31/2014
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Nationwide Children’s Hospital
Date Completed: 06/30/2014
Residency
Nationwide Children’s Hospital
Date Completed: 06/30/2011
Medical School
Northeastern Ohio Universities College of Medicine
Date Completed: 05/17/2008
- Pediatric Hematology Oncology
- Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-3550
- Fax us at:
- (614) 722-3369
- Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
